Shanghai Model Organisms Center (SMOC)
Shanghai provider of genetically engineered rodent models with phenotyping and in vivo pharmacology services.
16 contract research organizations in our directory list both Oncology Models and Rat among their capabilities, across 8 countries. 5 report GLP capability and 2 report AAALAC accreditation. Confirm species-specific experience with each lab when you get in touch.
Showing 16 CROs. Order rotates daily so no lab is permanently listed first.
Shanghai provider of genetically engineered rodent models with phenotyping and in vivo pharmacology services.
Kentucky CRO developing immunodeficient rat and mouse models, offering xenograft efficacy and safety studies in larger rodent hosts.
Independent Danish CRO focused on early in vivo pharmacology in rodents, with particular expertise in mouse cancer and immuno-oncology models.
Preclinical pharmacology CRO in Shanghai with specialty efficacy models in autoimmunity, inflammation, bone and orthopedics, oncology and metabolic disease, plus supporting PK/PD and exploratory toxicology.
Biomere (a JOINN company) is a preclinical CRO based in Worcester, MA. Services include non-GLP PK/PD, discovery toxicology, surgical services, disease models, and laboratory sciences. Surgical services include…
Not-for-profit research institute in Birmingham, Alabama providing contract drug discovery and preclinical development, including infectious disease and BSL-3 work, oncology models, ADME, bioanalysis, toxicology and…
Preclinical oncology and immuno-oncology CRO with orthotopic and metastatic models, whole-body imaging and GLP toxicology, with sites in Australia and the US.
Danish preclinical imaging CRO offering PET, SPECT, CT and MRI studies, radiopharmaceutical development support and oncology efficacy models.
Texas preclinical CRO offering xenograft and other oncology models, efficacy, pharmacology and toxicology studies.
Animal model company offering custom genetically engineered rodents together with in vivo pharmacology and AAV services, with operations in the US and China.
Preclinical efficacy CRO in the Boston area running predictive animal models across inflammation, mucositis, oncology-supportive care and other indications for biotech and pharma sponsors.
Lyon-based company creating genetically engineered and humanized rodent models, with catalog models and in vivo research services.
Finnish preclinical CRO focused on bone and joint disease, bone metastasis and oncology models, including osteoarthritis and osteoporosis efficacy studies.
Indian integrated drug discovery CRO offering in vivo pharmacology and DMPK alongside chemistry and biology.
Preclinical CRO in Northern Ireland, part of QIMA Life Sciences, running non-GLP rodent PK, dose range finding, biodistribution and disease model studies.
Integrated drug discovery CRO in Nottingham with in vivo pharmacology, DMPK and bioanalysis alongside chemistry and biology.